Suzuken Co., Ltd. (TYO:9987)
Japan
· Delayed Price · Currency is JPY 6,232.00
-118.00 (-1.86%)
At close: Mar 9, 2026
Suzuken Revenue
Suzuken had revenue of 666.19B JPY in the quarter ending December 31, 2025, with 3.87% growth. This brings the company's revenue in the last twelve months to 2.45T, up 1.50% year-over-year. In the fiscal year ending March 31, 2025, Suzuken had annual revenue of 2.40T with 0.56% growth.
Revenue (ttm)
2,446.91B
Revenue Growth
+1.50%
P/S Ratio
0.17
Revenue / Employee
189.35M
Employees
12,923
Market Cap
421.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2,399.95B | 13.46B | 0.56% |
| Mar 31, 2024 | 2,386.49B | 71.67B | 3.10% |
| Mar 31, 2023 | 2,314.83B | 82.05B | 3.67% |
| Mar 31, 2022 | 2,232.77B | 104.56B | 4.91% |
| Mar 31, 2021 | 2,128.22B | -85.26B | -3.85% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,257.94B |
| HOYA Corporation | 915.21B |
| Takeda Pharmaceutical Company | 4,464.58B |
| Daiichi Sankyo Company | 2,052.15B |
| Santen Pharmaceutical | 287.99B |
| COSMOS Pharmaceutical | 1,042.63B |
| Sundrug | 833.92B |
| Alfresa Holdings | 3,061.81B |